Business
Greenwich LifeSciences to Present at Multiple Investor Conferences, Including H.C. Wainwright Global Life Sciences and BIO-Europe Spring Conferences
STAFFORD, Texas--(BUSINESS WIRE)-- Greenwich LifeSciences, Inc. (Nasdaq: GLSI) (the “Company”), a clinical-stage biopharmaceutical company focused on the
About this update from Greenwich Lifesciences, Inc.
[{"type":"text","content":" STAFFORD, Texas--(BUSINESS WIRE)--\nGreenwich LifeSciences, Inc. (Nasdaq: GLSI) (the “Company”), a clinical-stage biopharmaceutical company focused on the development of GP2, an immunotherapy to prevent breast cancer recurrences in patients who have previously undergone surgery, today announced that Snehal Patel, CEO of Greenwich LifeSciences, will participate in multiple virtual investor conferences in March 2021.\n\nA previously recorded webcast of the Company’s presentation is available on the Company’s website here.\n\nH.C. Wainwright Global Life Sciences Conference 2021:\n\nThe Company will be participating in the H.C. Wainwright Global Life Sciences Conference with a virtual presentation that will be available on demand beginning on March 9th. In addition, the Company will be available to participate in one-on-one meetings with qualified members of the investor community who are registered to attend the conference. For more information, please visit the conference website at: https://hcwevents.com/globalconference/\n\nLandmark Health Innovations 2021:\n\nThe Company will be participating in the Landmark Health Innovations Conference with a live virtual presentation on March 11th at approximately 3:40 pm EST to High Net Worth and Family Office conference participants in this by-invitation event. Landmark’s Health Innovations 2021, a two-day virtual event, will feature virtual presentations from a roster of select companies, an expert keynote address, and an \"Investor Roundtable\" session to introduce Landmark’s investors. For more information, please visit the conference website at: https://www.landmarkangels.com/events\n\nBIO-Europe Spring 2021:\n\nThe Company will be participating in the BIO-Europe Spring partnering event from March 22-25 with an on-demand presentation available to conference participants. The BIO-Europe Spring 2021 program content includes business development, therapeutic areas, startup innovations, digital health, and scheduled one-on-one meetings. For more information, please visit the conference website at: https://informaconnect.com/bioeurope-spring/\n\nBenzinga Biotech Small-Cap Conference 2021:\n\nThe Company will be participating in the Benzinga Biotech Small-Cap Conference with a live 15 minute virtual presentation on March 25th to Benzinga’s small-cap investors followed by Q&A. The Company ma...